home.social

#chemicalproteomics — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #chemicalproteomics, aggregated by home.social.

fetched live
  1. Do you have experience in Organic Synthesis or Chemical Biology and are you looking for an exciting #postdoc position, in which you can apply your skills to the most exciting questions in microbiology? There are great opportunities available in the lab of Aaron Wright at Baylor University!

    ejof.fa.us2.oraclecloud.com/hc

    #Chemistry #ChemBio #ChemicalProteomics #ChemPro #ProteoProbes #Synthesis #Microbes

  2. Do you have experience in Organic Synthesis or Chemical Biology and are you looking for an exciting #postdoc position, in which you can apply your skills to the most exciting questions in microbiology? There are great opportunities available in the lab of Aaron Wright at Baylor University!

    ejof.fa.us2.oraclecloud.com/hc

    #Chemistry #ChemBio #ChemicalProteomics #ChemPro #ProteoProbes #Synthesis #Microbes

  3. Do you have experience in Organic Synthesis or Chemical Biology and are you looking for an exciting #postdoc position, in which you can apply your skills to the most exciting questions in microbiology? There are great opportunities available in the lab of Aaron Wright at Baylor University!

    ejof.fa.us2.oraclecloud.com/hc

    #Chemistry #ChemBio #ChemicalProteomics #ChemPro #ProteoProbes #Synthesis #Microbes

  4. Do you have experience in Organic Synthesis or Chemical Biology and are you looking for an exciting #postdoc position, in which you can apply your skills to the most exciting questions in microbiology? There are great opportunities available in the lab of Aaron Wright at Baylor University!

    ejof.fa.us2.oraclecloud.com/hc

    #Chemistry #ChemBio #ChemicalProteomics #ChemPro #ProteoProbes #Synthesis #Microbes

  5. Do you have experience in Organic Synthesis or Chemical Biology and are you looking for an exciting #postdoc position, in which you can apply your skills to the most exciting questions in microbiology? There are great opportunities available in the lab of Aaron Wright at Baylor University!

    ejof.fa.us2.oraclecloud.com/hc

    #Chemistry #ChemBio #ChemicalProteomics #ChemPro #ProteoProbes #Synthesis #Microbes

  6. Interesting @biorxivpreprint by Seungmin Ahn and Jung-Min Kee. They developed a thioacetylene-based probe for the chemoproteomic profiling of protein-based radicals, especially thiyl radicals in E. coli.

    doi.org/10.64898/2026.08.13.74

    #Chemistry #ChemBio #ChemPro #ChemicalProteomics

  7. Interesting @biorxivpreprint by Seungmin Ahn and Jung-Min Kee. They developed a thioacetylene-based probe for the chemoproteomic profiling of protein-based radicals, especially thiyl radicals in E. coli.

    doi.org/10.64898/2026.08.13.74

    #Chemistry #ChemBio #ChemPro #ChemicalProteomics

  8. Interesting @biorxivpreprint by Seungmin Ahn and Jung-Min Kee. They developed a thioacetylene-based probe for the chemoproteomic profiling of protein-based radicals, especially thiyl radicals in E. coli.

    doi.org/10.64898/2026.08.13.74

    #Chemistry #ChemBio #ChemPro #ChemicalProteomics

  9. Interesting @biorxivpreprint by Seungmin Ahn and Jung-Min Kee. They developed a thioacetylene-based probe for the chemoproteomic profiling of protein-based radicals, especially thiyl radicals in E. coli.

    doi.org/10.64898/2026.08.13.74

    #Chemistry #ChemBio #ChemPro #ChemicalProteomics

  10. Interesting @biorxivpreprint by Seungmin Ahn and Jung-Min Kee. They developed a thioacetylene-based probe for the chemoproteomic profiling of protein-based radicals, especially thiyl radicals in E. coli.

    doi.org/10.64898/2026.08.13.74

    #Chemistry #ChemBio #ChemPro #ChemicalProteomics

  11. Very much looking forward to the Symposium 𝐂𝐨𝐯𝐚𝐥𝐞𝐧𝐭 𝐌𝐨𝐝𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 in Cambridge (UK) on October 7th/8th!

    I am very happy to be part of an amazing lineup of speakers including Ed Tate, Matthias Gehringer, Louise Walport, Megan Wright, Elena De Vita, Matthew Bogyo, Scott Lovell, David Heppner, Jonathan Pettinger and Steven Gygi.

    Check out details and registration here: lnkd.in/eWHFdTFx

    #DrugDiscovery #ABPP #ChemicalProteomics #Symposium #ChemBio

  12. Very much looking forward to the Symposium 𝐂𝐨𝐯𝐚𝐥𝐞𝐧𝐭 𝐌𝐨𝐝𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 in Cambridge (UK) on October 7th/8th!

    I am very happy to be part of an amazing lineup of speakers including Ed Tate, Matthias Gehringer, Louise Walport, Megan Wright, Elena De Vita, Matthew Bogyo, Scott Lovell, David Heppner, Jonathan Pettinger and Steven Gygi.

    Check out details and registration here: lnkd.in/eWHFdTFx

    #DrugDiscovery #ABPP #ChemicalProteomics #Symposium #ChemBio

  13. Very much looking forward to the Symposium 𝐂𝐨𝐯𝐚𝐥𝐞𝐧𝐭 𝐌𝐨𝐝𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 in Cambridge (UK) on October 7th/8th!

    I am very happy to be part of an amazing lineup of speakers including Ed Tate, Matthias Gehringer, Louise Walport, Megan Wright, Elena De Vita, Matthew Bogyo, Scott Lovell, David Heppner, Jonathan Pettinger and Steven Gygi.

    Check out details and registration here: lnkd.in/eWHFdTFx

    #DrugDiscovery #ABPP #ChemicalProteomics #Symposium #ChemBio

  14. Very much looking forward to the Symposium 𝐂𝐨𝐯𝐚𝐥𝐞𝐧𝐭 𝐌𝐨𝐝𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐃𝐫𝐮𝐠 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲 in Cambridge (UK) on October 7th/8th!

    I am very happy to be part of an amazing lineup of speakers including Ed Tate, Matthias Gehringer, Louise Walport, Megan Wright, Elena De Vita, Matthew Bogyo, Scott Lovell, David Heppner, Jonathan Pettinger and Steven Gygi.

    Check out details and registration here: lnkd.in/eWHFdTFx

    #DrugDiscovery #ABPP #ChemicalProteomics #Symposium #ChemBio

  15. The authors use affinity-based protein profiling with photoaffinity probes to elucidate PTM-dependent changes in protein ligandability in the proteome. To induce global changes of the PTM landscape, they use broad spectrum inhibitors like staurosporine to inhibit protein kinases and tunicamycin to inhibit N-linked glycosylation. Very interesting findings that many ligand interactions are affected either by direct or downstream effects. (2/2)

    #ChemicalProteomics #ChemBio #DrugDiscovery #PAL #PTM

  16. The authors use affinity-based protein profiling with photoaffinity probes to elucidate PTM-dependent changes in protein ligandability in the proteome. To induce global changes of the PTM landscape, they use broad spectrum inhibitors like staurosporine to inhibit protein kinases and tunicamycin to inhibit N-linked glycosylation. Very interesting findings that many ligand interactions are affected either by direct or downstream effects. (2/2)

    #ChemicalProteomics #ChemBio #DrugDiscovery #PAL #PTM

  17. The authors use affinity-based protein profiling with photoaffinity probes to elucidate PTM-dependent changes in protein ligandability in the proteome. To induce global changes of the PTM landscape, they use broad spectrum inhibitors like staurosporine to inhibit protein kinases and tunicamycin to inhibit N-linked glycosylation. Very interesting findings that many ligand interactions are affected either by direct or downstream effects. (2/2)

    #ChemicalProteomics #ChemBio #DrugDiscovery #PAL #PTM

  18. The authors use affinity-based protein profiling with photoaffinity probes to elucidate PTM-dependent changes in protein ligandability in the proteome. To induce global changes of the PTM landscape, they use broad spectrum inhibitors like staurosporine to inhibit protein kinases and tunicamycin to inhibit N-linked glycosylation. Very interesting findings that many ligand interactions are affected either by direct or downstream effects. (2/2)

    #ChemicalProteomics #ChemBio #DrugDiscovery #PAL #PTM

  19. The authors use affinity-based protein profiling with photoaffinity probes to elucidate PTM-dependent changes in protein ligandability in the proteome. To induce global changes of the PTM landscape, they use broad spectrum inhibitors like staurosporine to inhibit protein kinases and tunicamycin to inhibit N-linked glycosylation. Very interesting findings that many ligand interactions are affected either by direct or downstream effects. (2/2)

    #ChemicalProteomics #ChemBio #DrugDiscovery #PAL #PTM

  20. A couple of weeks back I had the great opportunity to present some of our group's recent work in a virtual presentation at Rutgers University. A huge thank you to Joel Freundlich and Stephen Burley for inviting me (and for the gift that I just received). Thank you also to all that took the time to attend and participate in the discussion.

    #ChemicalProteomics #ChemPro #Presenting #Science #Chemistry

  21. A couple of weeks back I had the great opportunity to present some of our group's recent work in a virtual presentation at Rutgers University. A huge thank you to Joel Freundlich and Stephen Burley for inviting me (and for the gift that I just received). Thank you also to all that took the time to attend and participate in the discussion.

    #ChemicalProteomics #ChemPro #Presenting #Science #Chemistry

  22. A couple of weeks back I had the great opportunity to present some of our group's recent work in a virtual presentation at Rutgers University. A huge thank you to Joel Freundlich and Stephen Burley for inviting me (and for the gift that I just received). Thank you also to all that took the time to attend and participate in the discussion.

    #ChemicalProteomics #ChemPro #Presenting #Science #Chemistry

  23. A couple of weeks back I had the great opportunity to present some of our group's recent work in a virtual presentation at Rutgers University. A huge thank you to Joel Freundlich and Stephen Burley for inviting me (and for the gift that I just received). Thank you also to all that took the time to attend and participate in the discussion.

    #ChemicalProteomics #ChemPro #Presenting #Science #Chemistry

  24. A couple of weeks back I had the great opportunity to present some of our group's recent work in a virtual presentation at Rutgers University. A huge thank you to Joel Freundlich and Stephen Burley for inviting me (and for the gift that I just received). Thank you also to all that took the time to attend and participate in the discussion.

    #ChemicalProteomics #ChemPro #Presenting #Science #Chemistry

  25. Interesting ChemRxiv preprint by the group of Katrin Rittinger. They use enantiomeric pairs of covalent inhibitors to profile ligandable cysteines in the proteome. Interesting use of machine learning to predict new compounds that can add most to the ligandable space.

    doi.org/10.26434/chemrxiv.1500

    #ChemicalProbes #ChemicalProteomics #ProteoProbes #Chemistry #ChemBio #Ligandability #Cysteine #CovalentInhibitor

  26. Interesting ChemRxiv preprint by the group of Katrin Rittinger. They use enantiomeric pairs of covalent inhibitors to profile ligandable cysteines in the proteome. Interesting use of machine learning to predict new compounds that can add most to the ligandable space.

    doi.org/10.26434/chemrxiv.1500

    #ChemicalProbes #ChemicalProteomics #ProteoProbes #Chemistry #ChemBio #Ligandability #Cysteine #CovalentInhibitor

  27. Interesting ChemRxiv preprint by the group of Katrin Rittinger. They use enantiomeric pairs of covalent inhibitors to profile ligandable cysteines in the proteome. Interesting use of machine learning to predict new compounds that can add most to the ligandable space.

    doi.org/10.26434/chemrxiv.1500

    #ChemicalProbes #ChemicalProteomics #ProteoProbes #Chemistry #ChemBio #Ligandability #Cysteine #CovalentInhibitor

  28. Interesting ChemRxiv preprint by the group of Katrin Rittinger. They use enantiomeric pairs of covalent inhibitors to profile ligandable cysteines in the proteome. Interesting use of machine learning to predict new compounds that can add most to the ligandable space.

    doi.org/10.26434/chemrxiv.1500

    #ChemicalProbes #ChemicalProteomics #ProteoProbes #Chemistry #ChemBio #Ligandability #Cysteine #CovalentInhibitor

  29. Interesting ChemRxiv preprint by the group of Katrin Rittinger. They use enantiomeric pairs of covalent inhibitors to profile ligandable cysteines in the proteome. Interesting use of machine learning to predict new compounds that can add most to the ligandable space.

    doi.org/10.26434/chemrxiv.1500

    #ChemicalProbes #ChemicalProteomics #ProteoProbes #Chemistry #ChemBio #Ligandability #Cysteine #CovalentInhibitor

  30. RE: mstdn.science/@LED3hub/1160023

    Very much looking forward to the @LED3hub Lecture by Christina Woo! I am sure it will be a great one.

    If you are interested in #ChemicalProteomics and/or targeted protein degradation #TPD, you will not want to miss it.

    #Chemistry #ChemBio #DrugDiscovery #degrader

  31. RE: mstdn.science/@LED3hub/1160023

    Very much looking forward to the @LED3hub Lecture by Christina Woo! I am sure it will be a great one.

    If you are interested in #ChemicalProteomics and/or targeted protein degradation #TPD, you will not want to miss it.

    #Chemistry #ChemBio #DrugDiscovery #degrader

  32. RE: mstdn.science/@LED3hub/1160023

    Very much looking forward to the @LED3hub Lecture by Christina Woo! I am sure it will be a great one.

    If you are interested in #ChemicalProteomics and/or targeted protein degradation #TPD, you will not want to miss it.

    #Chemistry #ChemBio #DrugDiscovery #degrader

  33. RE: mstdn.science/@LED3hub/1160023

    Very much looking forward to the @LED3hub Lecture by Christina Woo! I am sure it will be a great one.

    If you are interested in #ChemicalProteomics and/or targeted protein degradation #TPD, you will not want to miss it.

    #Chemistry #ChemBio #DrugDiscovery #degrader

  34. RE: mstdn.science/@LED3hub/1160023

    Very much looking forward to the @LED3hub Lecture by Christina Woo! I am sure it will be a great one.

    If you are interested in #ChemicalProteomics and/or targeted protein degradation #TPD, you will not want to miss it.

    #Chemistry #ChemBio #DrugDiscovery #degrader

  35. We are looking forward to the LED3 Lecture of Christina Woo on February 26th. She will talk about "Rewriting Protein Modifications".

    If you are interested, make sure to come by!

    universiteitleiden.nl/en/scien

    #ChemBio #Chemistry #ChemicalProteomics #TPD

  36. We are looking forward to the LED3 Lecture of Christina Woo on February 26th. She will talk about "Rewriting Protein Modifications".

    If you are interested, make sure to come by!

    universiteitleiden.nl/en/scien

    #ChemBio #Chemistry #ChemicalProteomics #TPD

  37. We are looking forward to the LED3 Lecture of Christina Woo on February 26th. She will talk about "Rewriting Protein Modifications".

    If you are interested, make sure to come by!

    universiteitleiden.nl/en/scien

    #ChemBio #Chemistry #ChemicalProteomics #TPD

  38. We are looking forward to the LED3 Lecture of Christina Woo on February 26th. She will talk about "Rewriting Protein Modifications".

    If you are interested, make sure to come by!

    universiteitleiden.nl/en/scien

    #ChemBio #Chemistry #ChemicalProteomics #TPD

  39. We are looking forward to the LED3 Lecture of Christina Woo on February 26th. She will talk about "Rewriting Protein Modifications".

    If you are interested, make sure to come by!

    universiteitleiden.nl/en/scien

    #ChemBio #Chemistry #ChemicalProteomics #TPD

  40. A covalent KEAP1 activator in the clinics: A team at Vividion led by Matt Patricelli developed a covalent molecular glue for KEAP1, which leads to suppression of NRF2-dependent cancer growth. Excited to see, how the three clinical programs that Vividion built based on #CovalentInhibitors discovered by #ChemicalProteomics will progress. (7/12)
    aacrjournals.org/cancerdiscove

  41. A covalent KEAP1 activator in the clinics: A team at Vividion led by Matt Patricelli developed a covalent molecular glue for KEAP1, which leads to suppression of NRF2-dependent cancer growth. Excited to see, how the three clinical programs that Vividion built based on #CovalentInhibitors discovered by #ChemicalProteomics will progress. (7/12)
    aacrjournals.org/cancerdiscove

  42. A covalent KEAP1 activator in the clinics: A team at Vividion led by Matt Patricelli developed a covalent molecular glue for KEAP1, which leads to suppression of NRF2-dependent cancer growth. Excited to see, how the three clinical programs that Vividion built based on #CovalentInhibitors discovered by #ChemicalProteomics will progress. (7/12)
    aacrjournals.org/cancerdiscove

  43. A covalent KEAP1 activator in the clinics: A team at Vividion led by Matt Patricelli developed a covalent molecular glue for KEAP1, which leads to suppression of NRF2-dependent cancer growth. Excited to see, how the three clinical programs that Vividion built based on #CovalentInhibitors discovered by #ChemicalProteomics will progress. (7/12)
    aacrjournals.org/cancerdiscove

  44. A covalent KEAP1 activator in the clinics: A team at Vividion led by Matt Patricelli developed a covalent molecular glue for KEAP1, which leads to suppression of NRF2-dependent cancer growth. Excited to see, how the three clinical programs that Vividion built based on #CovalentInhibitors discovered by #ChemicalProteomics will progress. (7/12)
    aacrjournals.org/cancerdiscove

  45. Which cysteines are hyper-reactive in specific cancer types and tissues?

    The lab of Balyn Zaro addresses this question by measuring cysteine reactivity across the whole NCI-60 panel that includes nine different cancer types.
    cell.com/cell-chemical-biology

    Great to see them use the isoDTB tags that Patrick Zanon developed in our group for this extensive study. Glad that these tools are useful to other groups.
    onlinelibrary.wiley.com/doi/fu

    #ChemBio #Chemistry #ChemicalProteomics

  46. Which cysteines are hyper-reactive in specific cancer types and tissues?

    The lab of Balyn Zaro addresses this question by measuring cysteine reactivity across the whole NCI-60 panel that includes nine different cancer types.
    cell.com/cell-chemical-biology

    Great to see them use the isoDTB tags that Patrick Zanon developed in our group for this extensive study. Glad that these tools are useful to other groups.
    onlinelibrary.wiley.com/doi/fu

    #ChemBio #Chemistry #ChemicalProteomics

  47. Which cysteines are hyper-reactive in specific cancer types and tissues?

    The lab of Balyn Zaro addresses this question by measuring cysteine reactivity across the whole NCI-60 panel that includes nine different cancer types.
    cell.com/cell-chemical-biology

    Great to see them use the isoDTB tags that Patrick Zanon developed in our group for this extensive study. Glad that these tools are useful to other groups.
    onlinelibrary.wiley.com/doi/fu

    #ChemBio #Chemistry #ChemicalProteomics

  48. Which cysteines are hyper-reactive in specific cancer types and tissues?

    The lab of Balyn Zaro addresses this question by measuring cysteine reactivity across the whole NCI-60 panel that includes nine different cancer types.
    cell.com/cell-chemical-biology

    Great to see them use the isoDTB tags that Patrick Zanon developed in our group for this extensive study. Glad that these tools are useful to other groups.
    onlinelibrary.wiley.com/doi/fu

    #ChemBio #Chemistry #ChemicalProteomics

  49. Which cysteines are hyper-reactive in specific cancer types and tissues?

    The lab of Balyn Zaro addresses this question by measuring cysteine reactivity across the whole NCI-60 panel that includes nine different cancer types.
    cell.com/cell-chemical-biology

    Great to see them use the isoDTB tags that Patrick Zanon developed in our group for this extensive study. Glad that these tools are useful to other groups.
    onlinelibrary.wiley.com/doi/fu

    #ChemBio #Chemistry #ChemicalProteomics

  50. Interesting paper by the group of Rolf Breinbauer in Organic & Biomolecular Chemistry. They synthesized three α-fluoromethyl naphthoquinone-based probes as potentially reduction-activated probes for oxidoreductases, but found promiscuous reactivity.

    pubs.rsc.org/en/content/articl
    #Chemistry #ChemBio #ABPP #ChemPro #ProteoProbes #ChemicalProteomics

  51. Interesting paper by the group of Rolf Breinbauer in Organic & Biomolecular Chemistry. They synthesized three α-fluoromethyl naphthoquinone-based probes as potentially reduction-activated probes for oxidoreductases, but found promiscuous reactivity.

    pubs.rsc.org/en/content/articl
    #Chemistry #ChemBio #ABPP #ChemPro #ProteoProbes #ChemicalProteomics